Jesus Andres Beltran España
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jesus Andres Beltran España has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Cristian Orlando Porras Bueno
Pontificia Universidad Javeriana
4 shared publications - Ángel Alberto García Peña
Department of Internal Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
3 shared publications - Carolina Murgueitio Guzmán
Department of Internal Medicine Pontificia Universidad Javeriana Bogota Colombia
2 shared publications - Cándida Diaz-Brochero
Pontificia Universidad Javeriana
2 shared publications Daniel Fernandez Ávila
Department of Internal Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
1 shared publicationDaniel Fernández
Faculty of Medical and Health Sciences, Pontificia Universidad Javeriana, Bogotá, Colombia
1 shared publication
Latest Publications
- 14 July 2026
- Published by Wolters Kluwer Health in CIN: Computers, Informatics, Nursing
Lasting Empowerment After Discontinuing a Heart Failure Telemonitoring Program: A Randomized Controlled Trial.
This study evaluated the long-term effects of the ControlVit mobile application on clinical outcomes and patient empowerment in individuals with chronic heart failure (HF), 6 months after discontinuation of the app. In this open-label, randomized, controlled clinical trial, patients were assigned to either an intervention group receiving standard HF management plus the ControlVit app for 6 months or to a control group receiving standard care alone. After 6 months, app use was discontinued, and all participants were followed for an additional 6 months. The primary outcome was the composite of death or HF-related hospital readmission at 12 months, whereas secondary outcomes included changes in body weight, natriuretic peptide levels, New York Heart Association (NYHA) functional class, and patient empowerment, measured using the Empowerment Evaluation Scale (EES). A total of 140 patients were enrolled (28.6% women; mean age, 67 y). At 12 months, 8 patients (11.4%) in the intervention group and 3 patients (4.3%) in the control group experienced the primary outcome [relative risk (RR): 2.62; 95% CI: 0.73-9.52; P=.122). Empowerment levels were significantly higher among app users compared with controls (EES score: 4.68 ± 0.36 vs. 4.40 ± 1.91; P=.012). Use of SGLT2 inhibitors and ARNi increased significantly in both groups during follow-up (ControlVit: 60% to 85%, P<.001; Control: 51.4% to 75%, P<.001). Among outpatients with chronic HF participating in a structured HF program, the addition of a mobile telemonitoring application did not reduce mortality or HF readmissions 6 months after its discontinuation. However, the intervention was associated with sustained improvements in patient empowerment, suggesting a lasting behavioral impact beyond the period of active app use.
- 14 July 2026
- Published by Wolters Kluwer Health in CIN: Computers, Informatics, Nursing
Lasting Empowerment After Discontinuing a Heart Failure Telemonitoring Program: A Randomized Controlled Trial.
This study evaluated the long-term effects of the ControlVit mobile application on clinical outcomes and patient empowerment in individuals with chronic heart failure (HF), 6 months after discontinuation of the app. In this open-label, randomized, controlled clinical trial, patients were assigned to either an intervention group receiving standard HF management plus the ControlVit app for 6 months or to a control group receiving standard care alone. After 6 months, app use was discontinued, and all participants were followed for an additional 6 months. The primary outcome was the composite of death or HF-related hospital readmission at 12 months, whereas secondary outcomes included changes in body weight, natriuretic peptide levels, New York Heart Association (NYHA) functional class, and patient empowerment, measured using the Empowerment Evaluation Scale (EES). A total of 140 patients were enrolled (28.6% women; mean age, 67 y). At 12 months, 8 patients (11.4%) in the intervention group and 3 patients (4.3%) in the control group experienced the primary outcome [relative risk (RR): 2.62; 95% CI: 0.73-9.52; P=.122). Empowerment levels were significantly higher among app users compared with controls (EES score: 4.68 ± 0.36 vs. 4.40 ± 1.91; P=.012). Use of SGLT2 inhibitors and ARNi increased significantly in both groups during follow-up (ControlVit: 60% to 85%, P<.001; Control: 51.4% to 75%, P<.001). Among outpatients with chronic HF participating in a structured HF program, the addition of a mobile telemonitoring application did not reduce mortality or HF readmissions 6 months after its discontinuation. However, the intervention was associated with sustained improvements in patient empowerment, suggesting a lasting behavioral impact beyond the period of active app use.
- Open Access
- 14 August 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (8) , e70659
Unusual Syncope due to Intravascular Leiomyomatosis With Intracardiac Extension: A Case Report and Focused Literature Review
Intravascular leiomyomatosis with intracardiac extension is a rare disease that could cause syncope as the first manifestation. It should be suspected mostly in women of middle age with a medical history of uterine leiomyoma. Physicians must perform a multimodal imaging strategy to accurately characterize the mass's extension and perform the best treatment.
- 14 August 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (8) , e70659
Open AccessUnusual Syncope due to Intravascular Leiomyomatosis With Intracardiac Extension: A Case Report and Focused Literature Review
Intravascular leiomyomatosis with intracardiac extension is a rare disease that could cause syncope as the first manifestation. It should be suspected mostly in women of middle age with a medical history of uterine leiomyoma. Physicians must perform a multimodal imaging strategy to accurately characterize the mass's extension and perform the best treatment.
- Open Access
- 1 June 2025
- Published by SAGE Publications in Clinical Medicine Insights: Cardiology
- Vol. 19
Reliability and Readability Assessment of Atrial Fibrillation Patient Information Delivered by Artificial Intelligence-Based Language Models (ChatGPT, YouChat, Gemini, and Perplexity AI) in English and Spanish
Background: Atrial fibrillation (AF) is the most prevalent arrhythmia and a significant cause of morbidity. Artificial intelligence (AI)-based language models represent a novel tool for searching for medical information; however, there is still uncertainty regarding their reliability and readability in different languages. Objective: To assess the reliability and readability of information provided by AI-based models for patients with AF. Methods: A cross-sectional study was conducted to assess the reliability and readability of the responses generated by ChatGPT, YouChat, Gemini and Perplexity on AF in English and Spanish. Thirty standardised questions were posed in both languages. The quality of the responses was then assessed by 2 independent reviewers via a standardised tool. Readability was assessed via the Flesch–Szigrist formula. The results were then compared by tool and language. Results: ChatGPT demonstrated the highest interrater agreement (PA = 0.73 in Spanish, 0.80 in English), followed by Gemini in English (PA = 0.66). In Spanish, ChatGPT generated the highest percentage of complete responses (80%), followed by Perplexity (73%) and Gemini (47%). In English, Perplexity demonstrated the strongest performance, with a score of 93%, followed by ChatGPT, with 73%, and Gemini, with 53%. A readability analysis revealed significant differences between the models ( P < .01). The ChatGPT demonstrated the highest performance, although its content was moderately challenging in Spanish and highly challenging in English. Conclusion: ChatGPT and Perplexity emerged as the most reliable models, although readability remains a concern. There is a clear need for improvements to optimise the accuracy and accessibility of AI-generated medical information.
- 1 June 2025
- Published by SAGE Publications in Clinical Medicine Insights: Cardiology
- Vol. 19
Open AccessReliability and Readability Assessment of Atrial Fibrillation Patient Information Delivered by Artificial Intelligence-Based Language Models (ChatGPT, YouChat, Gemini, and Perplexity AI) in English and Spanish
Background: Atrial fibrillation (AF) is the most prevalent arrhythmia and a significant cause of morbidity. Artificial intelligence (AI)-based language models represent a novel tool for searching for medical information; however, there is still uncertainty regarding their reliability and readability in different languages. Objective: To assess the reliability and readability of information provided by AI-based models for patients with AF. Methods: A cross-sectional study was conducted to assess the reliability and readability of the responses generated by ChatGPT, YouChat, Gemini and Perplexity on AF in English and Spanish. Thirty standardised questions were posed in both languages. The quality of the responses was then assessed by 2 independent reviewers via a standardised tool. Readability was assessed via the Flesch–Szigrist formula. The results were then compared by tool and language. Results: ChatGPT demonstrated the highest interrater agreement (PA = 0.73 in Spanish, 0.80 in English), followed by Gemini in English (PA = 0.66). In Spanish, ChatGPT generated the highest percentage of complete responses (80%), followed by Perplexity (73%) and Gemini (47%). In English, Perplexity demonstrated the strongest performance, with a score of 93%, followed by ChatGPT, with 73%, and Gemini, with 53%. A readability analysis revealed significant differences between the models ( P < .01). The ChatGPT demonstrated the highest performance, although its content was moderately challenging in Spanish and highly challenging in English. Conclusion: ChatGPT and Perplexity emerged as the most reliable models, although readability remains a concern. There is a clear need for improvements to optimise the accuracy and accessibility of AI-generated medical information.
- Open Access
- 8 May 2025
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (4) , 869-877
Cardiovascular risk and lipid control in older adults: Compliance with LDL and non-HDL cholesterol and triglyceride goals in a national cross-sectional study
- 8 May 2025
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (4) , 869-877
Open AccessCardiovascular risk and lipid control in older adults: Compliance with LDL and non-HDL cholesterol and triglyceride goals in a national cross-sectional study
- Open Access
- 7 May 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (5) , e70146
Lipid Control and Social Determinants: Their Association With LDL and Non‐HDL Cholesterol Goals in Older Adults—A Population‐Based Study
Background: Social determinants of health (SDH) significantly influence cardiovascular outcomes; however, their role in achieving lipid profile goals in older adults remains underexplored. This study aimed to evaluate the association between SDH and nonachievement of LDL cholesterol (LDL‐C) and non‐HDL cholesterol (non‐HDL‐C) targets in Colombian adults aged ≥ 60 years.Methods: A cross‐sectional analysis was conducted using data from 1270 participants in the SABE Colombia 2015 study. Logistic regression was applied to estimate odds ratios (ORs) for not achieving LDL‐C and non‐HDL‐C goals on the basis of the Framingham, ASCVD 2013, and SCORE2 models.Results: Non achieving LDL‐C goals were associated with female sex, lack of affiliation with the health system and physical inactivity. Physical inactivity was associated with noncompliance on non‐HDL‐C goals, among others.Conclusions: SDH are strongly associated with poor lipid control. Addressing modifiable SDHs could enhance cardiovascular risk management in older adults.
- 7 May 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (5) , e70146
Open AccessLipid Control and Social Determinants: Their Association With LDL and Non‐HDL Cholesterol Goals in Older Adults—A Population‐Based Study
Background: Social determinants of health (SDH) significantly influence cardiovascular outcomes; however, their role in achieving lipid profile goals in older adults remains underexplored. This study aimed to evaluate the association between SDH and nonachievement of LDL cholesterol (LDL‐C) and non‐HDL cholesterol (non‐HDL‐C) targets in Colombian adults aged ≥ 60 years.Methods: A cross‐sectional analysis was conducted using data from 1270 participants in the SABE Colombia 2015 study. Logistic regression was applied to estimate odds ratios (ORs) for not achieving LDL‐C and non‐HDL‐C goals on the basis of the Framingham, ASCVD 2013, and SCORE2 models.Results: Non achieving LDL‐C goals were associated with female sex, lack of affiliation with the health system and physical inactivity. Physical inactivity was associated with noncompliance on non‐HDL‐C goals, among others.Conclusions: SDH are strongly associated with poor lipid control. Addressing modifiable SDHs could enhance cardiovascular risk management in older adults.